Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 40)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Nov-09 New Constructs, LLC N/A ALXN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ALEXION PHARM -- ALXN 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ALXN , ANSV , DCGN , HGSI , IDRA -- DRUGS 3 $4 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ALEXION PHARMACEUTICALS INC 5 $25 View Abstract
11-Nov-09 Datamonitor Datamonitor PLC Alexion Pharmaceuticals, Inc. - Company Profile 27 $50 View Abstract
11-Nov-09 Argus Research Corporation David Coleman Vickers Weekly Insider, 11/10/09 40 $50 View Abstract
Next 20

Brokerage Reports (Showing 1 to 8 of 8)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
10-Nov-09 Collins Stewart LLC Salveen J. Kochnover CFA ASH Abstracts Highlight Soliris in aHUS and LT PNH Data 5 $10 View Abstract
30-Oct-09 Collins Stewart LLC Salveen J. Kochnover CFA Key Takeaways from Dinner with Management 4 $10 View Abstract
23-Oct-09 Thomson StreetEvents N/A ALXN - Event Transcript of Alexion Pharmaceuticals conference call, Oct. 22, 2009 / 10:00am ET 23 $75 View Abstract
23-Oct-09 Thomson StreetEvents N/A ALXN - Event Brief of Alexion Pharmaceuticals conference call, Oct. 22, 2009 / 10:00am ET 25 $75 View Abstract
22-Oct-09 Collins Stewart LLC Salveen J. Kochnover CFA PNH and Pipeline Position ALXN Well for 2010 6 $25 View Abstract
22-Oct-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD ALXN: Strong 3Q09 Earnings – Raising Projections and Target Price 5 $10 View Abstract
22-Oct-09 Collins Stewart LLC Salveen J. Kochnover CFA First Take: Solid 3Q09 Organic Soliris Growth; FY09 Guidance Raised 3 $10 View Abstract
13-Oct-09 Collins Stewart LLC Salveen J. Kochnover CFA 3Q09 EPS Preview: Expect Soliris Sales to Reflect Organic Growth 4 $10 View Abstract

Independent Reports (Showing 1 to 10 of 32)

Release
Date Contributor Author Title Pages Price More Info
20-Nov-09 New Constructs, LLC N/A ALXN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ALEXION PHARM -- ALXN 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ALXN , ANSV , DCGN , HGSI , IDRA -- DRUGS 3 $4 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ALEXION PHARMACEUTICALS INC 5 $25 View Abstract
11-Nov-09 Datamonitor Datamonitor PLC Alexion Pharmaceuticals, Inc. - Company Profile 27 $50 View Abstract
11-Nov-09 Argus Research Corporation David Coleman Vickers Weekly Insider, 11/10/09 40 $50 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.